Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-10-10 00:00:00 ET · period of report 2023-10-09 · accession 0001770252-23-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-10 | 2023-10-09 | MYGN | Lambert Nicole | COO | F - Tax | $15.01 | -12.1K | 224.0K | -5% | -$181.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-09 | F | D | 4,864 | $15.01 | 231,240 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-09 | F | D | 7,247 | $15.01 | 223,993 | D | — | — |